Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01655420 · ClinicalTrials.gov registry record
Patient Reported Outcomes With LASIK: PROWL-2
A clinical trial of Laser in Situ Keratomileusis, sponsored by Food and Drug Administration (FDA).
- Completed
- Registry status
- 300
- Enrollment target
- 5
- Study locations
NCT01655420: Completed study of Laser in Situ Keratomileusis, sponsored by Food and Drug Administration (FDA).
NCT01655420 is a study of Laser in Situ Keratomileusis that has completed, run by Food and Drug Administration (FDA). The registered enrollment target is 300 participants. The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01655420, a study of Laser in Situ Keratomileusis, has completed, sponsored by Food and Drug Administration (FDA).
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
- 5
- Study locations
Study Summary
This study evaluates a questionaire designed to measure satisfaction and ophthalmic-related quality of life (QoL) of 300 civilian participants prior to and three months following state-of-the-art laser in situ keratomileusis (LASIK).
Conditions Studied
Interventions
- PROCEDURE LASIK
Study Locations (5)
California
- Stanford University School of Medicine - Stanford
Indiana
- 20/20 Institute - Indianapolis
Kansas
- Durrie Vision - Overland Park
Maryland
- Johns Hopkins University School of Medicine - Baltimore
South Dakota
- Vance Thompson Vision - Sioux Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2012-07 |
What the finished NCT01655420 record still lists
NCT01655420 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Laser in Situ Keratomileusis appearing as the primary indexed condition, and to 1 intervention - of which LASIK is the first listed.
NCT01655420 lists 5 locations in 5 states (California, Indiana, Kansas).
Frequently Asked Questions
What is clinical trial NCT01655420 about?
NCT01655420 is a clinical study titled "Patient Reported Outcomes With LASIK: PROWL-2". This study evaluates a questionaire designed to measure satisfaction and ophthalmic-related quality of life (QoL) of 300 civilian participants prior to and three months following state-of-the-art laser in situ keratomileusis (LASIK).
What is the current status of trial NCT01655420?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2012-07.
What conditions does trial NCT01655420 study?
This clinical trial studies the following conditions: Laser in Situ Keratomileusis.
What interventions are being tested in trial NCT01655420?
The interventions under investigation include: LASIK (PROCEDURE).
Who is sponsoring clinical trial NCT01655420?
This trial is sponsored by Food and Drug Administration (FDA), which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01655420 being conducted?
This trial has 5 study locations across California, Indiana, Kansas, Maryland, South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia